FOXO Technologies Inc. (FOXO)

USD 0.32

(-11.34%)

Market Cap (In USD)

5.67 Million

Revenue (In USD)

145 Thousand

Net Income (In USD)

-26.45 Million

Avg. Volume

269.31 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.13-1.3
PE
-
EPS
-
Beta Value
2.056
ISIN
US3514713052
CUSIP
-
CIK
1812360
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Mr. Mark Brian White
Employee Count
-
Website
https://www.foxotechnologies.com
Ipo Date
2022-09-16
Details
FOXO Technologies Inc., a technology platform company, focuses on commercializing longevity science through products and services that serve the life insurance industry. The company is developing products and services that combine longevity science with life insurance to support the consumer health and wellness engagement, and to simplify the consumer underwriting journey. It offers FOXO Labs, a services platform that integrates saliva-based epigenetic biomarkers into accelerated underwriting protocols to improve the customer underwriting journey; and FOXO Life, an insurance products platform that offers proprietary life insurance products and third-party life insurance carrier products based on bundling longevity science with life insurance. The company was founded in 2019 and is based in Minneapolis, Minnesota.